About Vanessa Wasta

Posts by Vanessa Wasta:

Cancer News Review


In this month's Cancer News Review podcast, Dr. William Nelson, director of the Johns Hopkins Kimmel Cancer Center discusses the top stories in cancer research.  First, he discusses recent news of DNA sequencing efforts in leukemia.  As the availability of genome sequencing technology grows, we can inventory all of the acquired defects that contribute to cancer, he says. Finding(...)

Sequencing Our Genes: What it Does and Doesn’t Do


This is the second blog in a three-part series. As technology that makes it possible to quickly sequence an individual’s whole genome becomes increasingly more available and affordable, people have begun to wonder about its ability to predict diseases a person is likely to develop.  If I had my whole genome sequenced, could it reveal whether(...)

Cancer News Review


Cancer headlines this past month included two studies on colonoscopy, a screening tool for colon cancer.  The first study looks at the long-term benefits of colonoscopy and found that 50 percent of colon cancer cases were avoided by a single colonscopy.  In the Cancer News Review podcast, William Nelson, M.D., Ph.D., director of the Johns Hopkins Kimmel Cancer(...)

Stand Up 2 Cancer Cites Progress


Yesterday afternoon, at the American Association for Cancer Research Meeting in Chicago, more than 150 people crowded a room to hear updates on research funded by Stand Up 2 Cancer (SU2C) and meet the new prostate cancer Dream Team. Arnold Levine, Ph.D., professor of pediatrics and biochemistry at the UMDNJ-Robert Wood Johnson Medical School opened(...)

Cancer News Review


Prostate cancer topics abound in the latest Cancer News Review podcast.  Dr. Bill Nelson, director of the Johns Hopkins Kimmel Cancer Center, discusses Hopkins-led research, published in the New England Journal of Medicine, looking at the genetic similarities of men with a family history of prostate cancer. By looking at their genes, investigators were able to find a genetic marker for(...)

More Good News on Melanoma Drug


Researchers from the Vanderbilt-Ingram Cancer Center and other institutions reported more data today on studies of a new melanoma drug that target products of a cancer-causing mutation in the BRAF gene. The study, published in the New England Journal of Medicine, tracked patients with metastatic melanoma who have been followed for more than a year(...)

What’s on Your Grocery List?


We completed three days of filming for a new C-Answers video series on cancer survivorship. In one of the video segments, we feature nutritionist Lynda McIntyre discussing how to stay healthy through diet and nutrition. Each time I listen to Lynda speak on these issues, I feel like my diet needs a complete makeover. But(...)

Creativity Competition Creates New Ideas to Cure Cancer


Last Friday, the historic Hurd Hall at Johns Hopkins was filled to capacity with students, faculty and staff waiting to hear five scientists – all in the early part of their careers – describe their novel ideas on how to cure metastatic cancer.  It was part of a competition on creative thinking named for John(...)

Top Trends in Cancer Research 2011


It's been a game-changing year in cancer research.  Doctors and scientists don't typically like to use those words, but here's why I think this is a turning point.  Scientists are churning out the genetic code of cancer cells as quickly as the cost of sequencing technology plummets.   Teams of researchers are looking for ways to add the new armory of cancer cell-targeted(...)